EMD-29523

Single-particle
3.9 Å
EMD-29523 Deposition: 23/01/2023
Map released: 12/07/2023
Last modified: 23/08/2023
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-29523

GC-C-Hsp90-Cdc37 regulatory complex

EMD-29523

Single-particle
3.9 Å
EMD-29523 Deposition: 23/01/2023
Map released: 12/07/2023
Last modified: 23/08/2023
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Cricetulus griseus, Homo sapiens
Sample: GC-C-Hsp90-Cdc37 regulatory complex
Fitted models: 8fx4 (Avg. Q-score: 0.329)
Raw data: EMPIAR-11568

Deposition Authors: Caveney NA , Garcia KC
Structural insight into guanylyl cyclase receptor hijacking of the kinase-Hsp90 regulatory mechanism.
Caveney NA , Tsutsumi N , Garcia KC
(2023) eLife , 12
PUBMED: 37535399
DOI: doi:10.7554/eLife.86784
ISSN: 2050-084X
Abstract:
Membrane receptor guanylyl cyclases play a role in many important facets of human physiology, from regulating blood pressure to intestinal fluid secretion. The structural mechanisms which influence these important physiological processes have yet to be explored. We present the 3.9 Å resolution cryo-EM structure of the human membrane receptor guanylyl cyclase GC-C in complex with Hsp90 and its co-chaperone Cdc37, providing insight into the mechanism of Cdc37 mediated binding of GC-C to the Hsp90 regulatory complex. As a membrane protein and non-kinase client of Hsp90-Cdc37, this work shows the remarkable plasticity of Cdc37 to interact with a broad array of clients with significant sequence variation. Furthermore, this work shows how membrane receptor guanylyl cyclases hijack the regulatory mechanisms used for active kinases to facilitate their regulation. Given the known druggability of Hsp90, these insights can guide the further development of membrane receptor guanylyl cyclase-targeted therapeutics and lead to new avenues to treat hypertension, inflammatory bowel disease, and other membrane receptor guanylyl cyclase-related conditions.